Two‐dimensional speckle‐tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia

Patients with acute myeloid leukemia (AML) are surviving longer. There are no data on changes in myocardial mechanics from standard of care low‐dose anthracycline‐based induction chemotherapy in older patients with AML. The aim of this study was to demonstrate the potential utility of strain imaging in detecting early changes in left ventricular function in this patient population after induction chemotherapy.

[1]  M. Handschumacher,et al.  Acute Leukemia is Associated with Cardiac Alterations before Chemotherapy , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  A. DeMichele,et al.  Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction. , 2016, JACC. Cardiovascular imaging.

[3]  Jennifer H. Jordan,et al.  Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors , 2016, Circulation. Cardiovascular imaging.

[4]  E. Halpern,et al.  Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  L. Shalaby,et al.  Early Ventricular Dysfunction After Anthracycline Chemotherapy in Children , 2016, Pediatric Cardiology.

[6]  H. Fernandez.  Beyond the first glance: anthracyclines in AML. , 2015, Blood.

[7]  James D. Thomas,et al.  Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study. , 2015, Journal of the American College of Cardiology.

[8]  Lucian Petrescu,et al.  Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. , 2013, Canadian journal of physiology and pharmacology.

[9]  Manish Bansal,et al.  Longitudinal and Circumferential Strain in Patients with Regional LV Dysfunction , 2013, Current Cardiology Reports.

[10]  Randolph P. Martin,et al.  Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab , 2012, Circulation. Cardiovascular imaging.

[11]  M. Relling,et al.  Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. DeCara.  Early Detection of Chemotherapy-Related Left Ventricular Dysfunction , 2012, Current Cardiology Reports.

[13]  Victor Mor-Avi,et al.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[14]  F. Veglia,et al.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. , 2010, Journal of the American College of Cardiology.

[15]  Michael S Ewer,et al.  Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. , 2004, Circulation.

[16]  P. Singal,et al.  Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.

[17]  A. Lincoff,et al.  Anthracycline-Induced Cardiotoxicity , 1996, Annals of Internal Medicine.

[18]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.